{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:54:28Z","timestamp":1792284868967,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.maturitas.2007.02.013","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T07:17:26Z","timestamp":1174979846000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Risk and risk assessment for breast cancer: Molecular and clinical aspects"],"prefix":"10.1016","volume":"57","author":[{"given":"M.W.","family":"Beckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Bani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Strick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Lux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2007.02.013_bib1","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1055\/s-2004-821050","article-title":"Hereditary breast and ovarian cancer: an update. Part I: molecular basics, genetic counselling and risk calculation","volume":"64","author":"Fasching","year":"2004","journal-title":"Geburtsh Frauenheilk"},{"key":"10.1016\/j.maturitas.2007.02.013_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.maturitas.2007.02.013_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.maturitas.2007.02.013_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R","article-title":"Risk models for familial ovarian and breast cancer","volume":"18","author":"Antoniou","year":"2000","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.maturitas.2007.02.013_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1086\/302530","article-title":"Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer","volume":"65","author":"Dorum","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.maturitas.2007.02.013_bib6","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.maturitas.2007.02.013_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.maturitas.2007.02.013_bib8","first-page":"1031","article-title":"BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2","volume":"60","author":"Schubert","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.maturitas.2007.02.013_bib9","first-page":"1079","article-title":"Study of a single BRCA2 mutation with high carrier frequency in a small population","volume":"60","author":"Thorlacius","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.maturitas.2007.02.013_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.GIM.0000151155.36470.FF","article-title":"Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications","volume":"7","author":"McClain","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.maturitas.2007.02.013_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/35077207","article-title":"Cancer genetics","volume":"411","author":"Ponder","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.maturitas.2007.02.013_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/bcr448","article-title":"Familial risks of breast cancer","volume":"4","author":"Easton","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.maturitas.2007.02.013_bib13","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/S0959-8049(00)00180-5","article-title":"The requirements of a specialist breast unit","volume":"36","author":"The European Society of Mastology","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.maturitas.2007.02.013_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast-cancer prevention trials","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2007.02.013_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3816\/CBC.2000.n.011","article-title":"Prophylactic surgery for women at high risk for breast cancer","volume":"1","author":"Blanchard","year":"2000","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.maturitas.2007.02.013_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2007.02.013_bib17","first-page":"100S","article-title":"Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"18","author":"Rebbeck","year":"2000","journal-title":"J Clin Oncol"},{"issue":"Suppl. 6","key":"10.1016\/j.maturitas.2007.02.013_bib18","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0959-8049(02)00269-1","article-title":"Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"38","author":"Rebbeck","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.maturitas.2007.02.013_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2007.02.013_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5694\/j.1326-5377.2003.tb05069.x","article-title":"Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review","volume":"178","author":"Butow","year":"2003","journal-title":"Med J Aust"},{"key":"10.1016\/j.maturitas.2007.02.013_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1015269620265","article-title":"One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery)","volume":"73","author":"Lodder","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.maturitas.2007.02.013_bib22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2003.05.096","article-title":"Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist","volume":"21","author":"Lynch","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.maturitas.2007.02.013_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1148\/radiology.215.1.r00ap01267","article-title":"Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results","volume":"215","author":"Kuhl","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.maturitas.2007.02.013_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1006480106487","article-title":"First experiences in screening women at high risk for breast cancer with MR imaging","volume":"63","author":"Tilanus-Linthorst","year":"2000","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.maturitas.2007.02.013_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00008469-200508000-00014","article-title":"Use of intensified early cancer detection in high-risk patients with familiar breast and ovarian cancer","volume":"14","author":"Lux","year":"2005","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"10.1016\/j.maturitas.2007.02.013_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00008469-200512000-00003","article-title":"Age of uptake of early cancer detection facilities by low-risk and in high-risk patients with familial breast and ovarian cancer","volume":"14","author":"Lux","year":"2005","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.maturitas.2007.02.013_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.ogx.0000151669.38495.2e","article-title":"Efficacy of magnetic resonance imaging and mammography for breast cancer screening in women with a familial or genetic predisposition","volume":"60","author":"Kriege","year":"2005","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.maturitas.2007.02.013_bib28","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2007.02.013_bib29","first-page":"232","article-title":"Genetic analysis of breast cancer in the cancer and steroid hormone study","volume":"48","author":"Claus","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.maturitas.2007.02.013_bib30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2007.02.013_bib31","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1997.03550150046034","article-title":"BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing","volume":"278","author":"Shattuck-Eidens","year":"1997","journal-title":"Jama"},{"key":"10.1016\/j.maturitas.2007.02.013_bib32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","article-title":"BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer","volume":"336","author":"Couch","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2007.02.013_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.maturitas.2007.02.013_bib34","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/bcr644","article-title":"Log odds of carrying an ancestral mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)","volume":"5","author":"Apicella","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.maturitas.2007.02.013_bib35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.maturitas.2007.02.013_bib36","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancer","volume":"91","author":"Antoniou","year":"2004","journal-title":"Br J Cancer"},{"issue":"17","key":"10.1016\/j.maturitas.2007.02.013_bib37","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/djj331","article-title":"Prospective breast cancer risk prediction model for women undergoing screening mammography","volume":"98","author":"Barlow","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2007.02.013_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jnci\/89.3.227","article-title":"Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history","volume":"89","author":"Berry","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2007.02.013_bib39","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/oxfordjournals.aje.a114994","article-title":"Familial ovarian cancer: a population-based case-control study","volume":"128","author":"Schildkraut","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2007.02.013_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4065\/72.1.54","article-title":"Genetics of breast cancer","volume":"72","author":"Greene","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.maturitas.2007.02.013_bib41","first-page":"547","article-title":"Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2","volume":"59","author":"Rebbeck","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.maturitas.2007.02.013_bib42","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/sj.bjc.6690235","article-title":"Characteristics of small breast and\/or ovarian cancer families with germline mutations in BRCA1 and BRCA2","volume":"79","author":"Ligtenberg","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.maturitas.2007.02.013_bib43","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.maturitas.2007.02.013_bib44","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","article-title":"BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes","volume":"20","author":"Berry","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.maturitas.2007.02.013_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jmg.39.4.225","article-title":"Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility","volume":"39","author":"de Jong","year":"2002","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.maturitas.2007.02.013_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00109-005-0696-7","article-title":"Hereditary breast and ovarian cancer: review and future perspectives","volume":"84","author":"Lux","year":"2006","journal-title":"J Mol Med"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512207000746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512207000746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:42:48Z","timestamp":1759912968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512207000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0378512207000746"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2007.02.013","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk and risk assessment for breast cancer: Molecular and clinical aspects","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2007.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}